Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
45.06 USD | +18.91% | +20.32% | +12.22% |
Sales 2024 * | - | Sales 2025 * | 44.94M 3.58B | Capitalization | 1.27B 101B |
---|---|---|---|---|---|
Net income 2024 * | -57M -4.54B | Net income 2025 * | -30M -2.39B | EV / Sales 2024 * | - |
Net cash position 2024 * | 139M 11.06B | Net cash position 2025 * | 99.6M 7.93B | EV / Sales 2025 * | 26 x |
P/E ratio 2024 * |
-24.2
x | P/E ratio 2025 * |
-50.3
x | Employees | 33 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.79% |
Latest transcript on Soleno Therapeutics, Inc.
1 day | +31.25% | ||
1 week | +37.27% | ||
Current month | +20.40% | ||
1 month | +24.20% | ||
3 months | +7.38% | ||
6 months | +122.60% | ||
Current year | +28.03% |
Managers | Title | Age | Since |
---|---|---|---|
Anish Bhatnagar
CEO | Chief Executive Officer | 56 | 31/12/05 |
James Mackaness
DFI | Director of Finance/CFO | 60 | 13/11/19 |
Ernest Mario
CHM | Chairman | 85 | 02/08/07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ernest Mario
CHM | Chairman | 85 | 02/08/07 |
Gwen Melincoff
BRD | Director/Board Member | 72 | 25/04/19 |
Bill Harris
BRD | Director/Board Member | 65 | 01/06/14 |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 45.12 | +19.08% | 2 914 252 |
26/04/24 | 37.89 | +1.47% | 138,612 |
25/04/24 | 37.34 | -5.08% | 269,361 |
24/04/24 | 39.34 | -1.99% | 335,907 |
23/04/24 | 40.14 | +6.93% | 416,661 |
Delayed Quote Nasdaq, April 29, 2024 at 04:20 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.03% | 1.27B | |
-2.33% | 103B | |
+1.94% | 95.28B | |
+1.60% | 22.15B | |
-15.29% | 21.02B | |
-8.58% | 18.15B | |
-41.01% | 16.73B | |
-12.85% | 16.05B | |
+4.36% | 13.68B | |
+35.54% | 12.17B |
- Stock Market
- Equities
- SLNO Stock